Addition of the PCSK9 inhibitor evolocumab to statin therapy after cardiac bypass surgery did not improve 24-month graft patency in the NEWTON-CABG CardioLink-5 trial. Subodh Verma, MD, cardiac ...

MADRID, Spain—The European Society of Cardiology and the European Atherosclerosis Society (ESC/EAS) have updated their guidelines for the management of dyslipidemia, and while treatment goals have ...

Adding a PCSK9 inhibitor to maximally tolerated statins after a coronary or peripheral artery revascularization can help patients achieve LDL cholesterol goals better than standard care, data from the ...

For some people with high cholesterol, making lifestyle changes and taking routine statin medications may not be sufficient to help them reach their target cholesterol levels. For these patients, a ...

NEW ORLEANS — Lowering the level of low-density lipoprotein (LDL) cholesterol to below 40 mg/dL — well beneath current poststroke guideline targets — reduced major cardiovascular events without ...

Among people with a previous heart attack or stroke, or who are at high risk for one, a daily oral medication may offer an effective alternative to injections of PCSK9 inhibitors to lower low-density ...

Daiichi Sankyo Europe is pleased to announce the development of a fixed-triple oral combination lipid-lowering tablet of bempedoic acid, ezetimibe, and different doses of a statin, with the potential ...

* The Portfolio Diet blends key cholesterol-lowering foods like oats, soy, nuts, and plant sterols * Following this diet can lower bad cholesterol levels by nearly 28 //percent, similar to statin ...